In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Large scale and complex energy deals: Five priorities to drive success post-close
Up to 90% of M&A deals are regarded as failures and 83% of M&A deals fail to boost shareholder returns. Post-transaction playbooks are a known tool, helpful in...